The L&G Pharma Breakthrough UCITS ETF is an Exchange Traded Fund that owns shares in pharmaceutical companies, that looks for Long-term value in the pharmaceutical sub-sector that benefits from certain commercial and regulatory incentives.
It’s top ten holdings are:-
Array BioPharma 6.6% of the fund
PTC Therapeutics 4.2% of the fund
PharmaMar 4.0% of the fund
Grifols 3.7% of the fund
CSL 3.6% of the fund
Nippon Shinyaku 3.6% of the fund
Celgene 3.6% of the fund
Jazz Pharmaceuticals 3.4% of the fund
Novartis 3.3% of the fund
Ipsen 3.3% of the fund
https://www.shareshop.hsbc.co.uk/shareshop/security.cgi?csi=54634586&action=